Idiopathic Pulmonary Fibrosis Clinical Trials

A listing of Idiopathic Pulmonary Fibrosis medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Birmingham Alabama 35294

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

Birmingham Alabama 35233

A clinical research study of GBT440 and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Birmingham Alabama 35233

A clinical trial seeking patients for a research study for the treatment of Idiopathic Pulmonary Fibrosis

Birmingham Alabama 35294

Patients are needed to participate in a clinical research study of Nintedanib, Placebo and Sildenafil to evaluate Idiopathic Pulmonary Fibrosis

Arizona

Phoenix Arizona 85013

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

Phoenix Arizona 85006

Patients are needed to participate in a clinical research study evaluating KD025 and Standard of Care for the treatment of Idiopathic Pulmonary Fibrosis

Tucson Arizona 85724

Patients are needed to participate in a clinical research study evaluating KD025 and Standard of Care for the treatment of Idiopathic Pulmonary Fibrosis

California

La Jolla California 92037

A clinical research study of Pirfenidone and Vismodegib for the treatment of Idiopathic Pulmonary Fibrosis

Los Angeles California 90024

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

Los Angeles California 90095-1690

A clinical trial seeking patients for a research study for the treatment of Pulmonary Arterial Hypertension, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease or Pulmonary Hypertension

Los Angeles California 90095

Patients are needed to participate in a clinical research study evaluating treprostinil for the treatment of Pulmonary Arterial Hypertension, Interstitial Lung Disease or Idiopathic Pulmonary Fibrosis

Los Angeles California 90095-1690

Patients are needed to participate in a clinical research study of bosentan and No specific intervention to evaluate Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

View More ▼

Los Angeles California 90095-1690

Patients are needed to participate in a clinical research study of bosentan and No specific intervention to evaluate Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

Sacramento California 95817

Patients are needed to participate in a clinical research study evaluating KD025 and Standard of Care for the treatment of Idiopathic Pulmonary Fibrosis

Stanford California 94305

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

Colorado

Denver Colorado 80206

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

Denver Colorado 80206

A clinical research study of GBT440 and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Denver Colorado 80206

A clinical trial seeking patients for a research study for the treatment of Idiopathic Pulmonary Fibrosis

Connecticut

New Haven Connecticut 06520

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

Stamford Connecticut 06902

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

Stamford Connecticut 06902-3633

Patients are needed to participate in a clinical research study of Nintedanib, Placebo and Sildenafil to evaluate Idiopathic Pulmonary Fibrosis

Florida

Pulmonary Disease Specialists, PA, d/b/a PDS Research
Kissimmee Florida

STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

University of Miami Pulmonary Clinics
Miami Florida 33136

STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

View More ▼

Clearwater Florida 33765

Patients are needed to participate in a clinical research study evaluating KD025 and Standard of Care for the treatment of Idiopathic Pulmonary Fibrosis

Jacksonville Florida 32209

Patients are needed to participate in a clinical research study of Nintedanib, Placebo and Sildenafil to evaluate Idiopathic Pulmonary Fibrosis

Kissimmee Florida 34741

Patients are needed to participate in a clinical research study evaluating KD025 and Standard of Care for the treatment of Idiopathic Pulmonary Fibrosis

Orlando Florida 32803

Patients are needed to participate in a clinical research study evaluating KD025 and Standard of Care for the treatment of Idiopathic Pulmonary Fibrosis

Georgia

Emory University
Atlanta Georgia 30322

STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

View More ▼

Austell Georgia 30106

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

Illinois

Chicago Illinois 60637

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

Chicago Illinois 60637

Patients are needed to participate in a clinical research study of Nintedanib, Placebo and Sildenafil to evaluate Idiopathic Pulmonary Fibrosis

Indiana

Muncie Indiana 47303

A clinical research study of Pirfenidone and Vismodegib for the treatment of Idiopathic Pulmonary Fibrosis

Kansas

University of Kansas
Kansas City Kansas

STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

View More ▼

Kansas City Kansas 66160

A clinical research study of GBT440 and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Kansas City Kansas 66160

Patients are needed to participate in a clinical research study of Nintedanib, Placebo and Sildenafil to evaluate Idiopathic Pulmonary Fibrosis

Kentucky

Baptist Health Clinical Research Center & Lexington Cardiac Research Foundation
Lexington Kentucky 40353

Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry

View More ▼

Lexington Kentucky 40503

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

Louisville Kentucky 40202

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

Louisiana

New Orleans Louisiana 70112

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

New Orleans Louisiana 70122

A clinical research study of GBT440 and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

New Orleans Louisiana 70122

A clinical trial seeking patients for a research study for the treatment of Idiopathic Pulmonary Fibrosis

Massachusetts

Brigham and Women's Hospital
Boston Massachusetts 02116

STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Massachusetts General Hospital
Boston Massachusetts 02114

STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

View More ▼

Burlington Massachusetts 01803

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

Michigan

Ann Arbor Michigan 48109

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

Ann Arbor Michigan 48109

Patients are needed to participate in a clinical research study of Nintedanib, Placebo and Sildenafil to evaluate Idiopathic Pulmonary Fibrosis

Minnesota

Minneapolis Minnesota 55455

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

Minneapolis Minnesota 55407

Patients are needed to participate in a clinical research study of Nintedanib, Placebo and Sildenafil to evaluate Idiopathic Pulmonary Fibrosis

Missouri

The Lung Research Center
Chesterfield Missouri 63017

A 12-week, double blind, randomised, placebo controlled, parallel group trial followed by a single active arm phase of 40 weeks evaluating the effect of oral nintedanib 150 mg twice daily on change in biomarkers of extracellular matrix (ECM) turnover in patients with idiopathic pulmonary fibrosis (IPF) and limited forced vital capacity (FVC) impairment.

The Lung Research Center
Chesterfield Missouri 63017

A 24-week, double-blind, randomized, parallel-group study evaluating the efficacy and safety of oral nintedanib coadministered with oral sildenafil, compared to treatment with nintedanib alone, in patients with idiopathic pulmonary fibrosis (IPF) and advanced lung function impairment